Magnetic resonance imaging measures of brain atrophy in multiple sclerosis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Magnetic resonance imaging (MRI) has been widely used to diagnose and monitor multiple sclerosis (MS). Although MRI‐visible lesions are a key feature of MS, they are thought to correlate poorly with clinical progression. Neurodegeneration is increasingly being recognized as an important factor in the pathogenesis of MS, and MRI measures of brain atrophy have been suggested as surrogate markers of neuroaxonal loss and disease progression. This pathology may be more relevant to the progression of disability than focal inflammation. A number of MRI‐based methods have been developed for the measurement of global and regional brain atrophy. Natural‐history studies of MS and clinically isolated syndromes suggestive of MS have observed atrophy in these subjects above that seen in controls, over periods ranging from three months to years. Brain atrophy has also been incorporated as an outcome measure in therapeutic trials of disease‐modifying treatments. This paper considers neuroaxonal loss and the pathological basis of brain atrophy, methods developed to quantify brain atrophy, the findings of natural‐history and therapeutic studies, the relationship of brain atrophy to disability and cognition, and the future research directions and clinical applications of brain atrophy measurements. J. Magn. Reson. Imaging 2006. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“Nonparametric nonuniform intensity normalization (N3), as proposed by Sled et al (58), is a widely used and fully automated method that is applied postacquisition to correct for tissue inhomogeneity.”
MethodAxonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 2×
“In addition, significant decreases in axonal number and density have been observed in normal-appearing WM (NAWM) (4), and axonal transection and loss underlies gray matter (GM) lesions found at postmortem (5).”
BackgroundBabbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861 · cited 1×
“, optic neuritis) and have MRI-visible brain lesions develop clinically definite MS (60).”
BackgroundSelf-citationHistopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656 · cited 1×
“Axonal density has been shown to vary between 0% to 100% of normal within chronic and acute white matter (WM) lesions (2,3).”
BackgroundWilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04967.2003 · Cited by 337 · cited 2×
“Equally, degeneration has been shown to occur despite intact surrounding myelin (16).”
BackgroundCouncilman, W. T. (1898) · Journal of Experimental Medicine · doi:10.1084/jem.3.4-5.393 · Cited by 159
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Gray matter atrophy is related to long‐term disability in multiple sclerosis
Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21423 · Cited by 500
Self-citationon behalf of the MAGNIMS study group, Rovira, À., Wattjes, M. P., Tintoré, M., Tur, C., Yousry, T. A., Sormani, M. P., De Stefano, N., Filippi, M., Auger, C., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.106 · Cited by 423
Self-citationFocal cortical atrophy in multiple sclerosis: Relation to lesion load and disability
Charil, A., Dagher, A., Lerch, J. P., Zijdenbos, A. P., Worsley, K. J., & Evans, A. C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.006 · Cited by 194
“However, more recent studies have demonstrated the presence of gray matter (GM) lesions (Peterson et al., 2001; Geurts et al., 2005) and brain atrophy (Chard et al., 2002; Anderson et al., 2006).”
BackgroundReview: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Brain Atrophy and Cerebral Small Vessel Disease: A Prospective Follow-Up Study
Nitkunan, A., Lanfranconi, S., Charlton, R. A., Barrick, T. R., & Markus, H. S. (2011) · Stroke · doi:10.1161/strokeaha.110.594267 · Cited by 135
Progressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
Blau, C. W., Cowley, T. R., O'Sullivan, J., Grehan, B., Browne, T. C., Kelly, L., Birch, A., Murphy, N., Kelly, A. M., Kerskens, C. M., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.035 · Cited by 92
“Thus local increases in brain T1 relaxation time have been linked with acute astrocyte activation (Anderson et al., 2006; Sibson et al., 2008), while the age-related increase in glial fibrillary acidic protein (GFAP) expression and immunoreactivity was also accompanied by increased T1 relaxation…”
BackgroundKallaur, A. P., Oliveira, S. R., Simão, A. N. C., Alfieri, D. F., Flauzino, T., Lopes, J., de Carvalho Jennings Pereira, W. L., de Meleck Proença, C., Borelli, S. D., Kaimen-Maciel, D. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9846-x · Cited by 75
“Progressive MS patients enrolled in the present study exhibited no differences in lesion location and presented increased gadolinium-positive lesion evaluated by MRI, a result that is in contrast to previous studies [36, 37], which showed that new lesions and gadolinium-enhanced lesions are rare or absent in patients…”
Result
Metadata
- Authors
- Anderson, V. M., Fox, N. C., & Miller, D. H.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2006-04-04
- Volume
- 23
- Issue
- 5
- Pages
- 605-618
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2017436306
- Cited by
- 116
- References
- 9
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.